F. Santé-publique, COVID-19 : point épidémiologique du, vol.7

. Coronavirus,

W. Liang, W. Guan, and R. Chen, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, vol.21, pp.335-337, 2020.

L. Zhang, F. Zhu, and L. Xie, Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China, Ann Oncol, vol.31, issue.7, pp.894-901, 2020.

L. Rosenbaum, The Untold Toll -The Pandemic's Effects on Patients without Covid-19, N Engl J Med, vol.382, issue.24, pp.2368-2371, 2020.

S. Mayor, COVID-19: impact on cancer workforce and delivery of care, Lancet Oncol, vol.21, p.633, 2020.

A. Ho, W. Alhazzani, and A. Alhuraiji, A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group, Oncologist, 2020.

J. M. Marron, S. Joffe, R. Jagsi, R. A. Spence, and F. J. Hlubocky, Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic, J Clin Oncol, vol.38, pp.2201-2205, 2019.

D. Yerramilli, A. J. Xu, and E. F. Gillespie, Palliative Radiotherapy for Oncologic Emergencies in the setting of COVID-19: Approaches to Balancing Risks and Benefits, Adv Radiat Oncol, 2020.

C. N. Catton, H. Lukka, and C. Gu, Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer, J Clin Oncol, vol.35, pp.1884-1890, 2017.

T. J. Whelan, J. Pignol, and M. N. Levine, Long-term results of hypofractionated radiation therapy for breast cancer, N Engl J Med, vol.362, pp.513-520, 2010.

D. Rades, B. ?egedin, and A. J. Conde-moreno, Radiotherapy With 4 Gy ×5 Versus 3 Gy ×10 for Metastatic Epidural Spinal Cord Compression: Final Results of the SCORE-2 Trial

, J Clin Oncol, vol.34, pp.597-602, 2016.

S. A. Mansfield, M. Abdel-rasoul, A. M. Terando, and D. M. Agnese, Timing of breast cancer surgery-how much does it matter?, Breast J, vol.23, pp.444-451, 2017.

R. Van-den-bergh, P. C. Albertsen, and C. H. Bangma, Timing of curative treatment for prostate cancer: a systematic review, Eur Urol, vol.64, pp.204-215, 2013.

S. J. Sirintrapun and A. M. Lopez, Telemedicine in cancer care, Am Soc Clin Oncol Educ Book, vol.38, pp.540-545, 2018.

D. Schrag, D. L. Hershman, and E. Basch, Oncology practice during the COVID-19 Pandemic, JAMA, vol.2020

M. Lambertini, A. Toss, and A. Passaro, COVID-19) in Italy: young oncologists' perspective, ESMO Open, vol.2020, p.5, 2019.

. Esmo, Cancer Patient Management During the COVID-19

T. P. Hanna, G. A. Evans, and C. M. Booth, Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic, Nat Rev Clin Oncol, vol.17, pp.268-270, 2020.

C. M. Dobson, A. J. Russell, and G. P. Rubin, Patient delay in cancer diagnosis: what do we really mean and can we be more specific? BMC, Health Serv Res, vol.14, p.387, 2014.

D. Waterhouse, R. Harvey, and P. Hurley, Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-term Opportunities for Transformation: Findings from an

A. G. Dinmohamed, O. Visser, and R. Verhoeven, Evaluation of medical practices in oncology in the context of the COVID-19 pandemic in France: Physicians' point of view: the PRATICOVID study, Cancer Med, vol.00, pp.1-9, 2020.